Take part of the vision to make Scandinavia to
biomedicine centre of Europe
by Creating a common Bio Medical Database in
Scandinavia
Jens Gran
Manager Medcoast Scandinavia
Stratinc Seminar Monday, 24th May 2004
Developing a Borderless
Bio Medical Region
The GO-region
Göteborg & Oslo
The purpose is to stimulate
• economic development
• trade and industry
• research and education
• communications
• culture and tourism
Facts of the GO-region
• Sweden and Norway have close relations past
and present.
• The region is a gateway to the Nordic Countries.
• There live about 3 million people in the region.
• The closest university for Göteborg University is
University of Oslo and vica versa.
• The academic institutions in the region have
about 100 000 students and 4 000 researchers.
• There are several Science Parks in the region.
MedCoast Scandinavia
• The initiative came from universities in the region:
University of Oslo, Agricultural University of Norway,
Norwegian School of Veterinary Medicine, Gøteborg
University,Chalmers University of Technology, and
the GO partners.
• The cooperation agreement was signed spring 2002.
• The board consists of representative from the
academic institutions and the political bodies in the
region.
The organisations in the region
MedCoast Scandinavia
Building network in Göteborg-Oslo
between industry, academia and
public sector in order to increase
growth within biomedicine. Initiate
cross-boarder projects between
research and industry for
development of new products.
Does biomedical bench-marking.
The GO-region and the
Scandinavian Arena
Politically driven mainly for
questions related to infrastructure,
environment and business in
Oslo/Gothenburg/Copenhagen.
NBA
SwedenBio
Business Region Göteborg
Business area Biomedicine
with several projects in order
to enhance the biomedical
sector in Gothenburg.
Uppsala Bio
Driven by the academia,
industry and public sector to
enhance growth within
biomedicine in Uppsala.
Stockholm BioScience
Driven by the academia to
establish an arena for multidisciplinary research and
commercial activities in
Stockholm.
Oslo Teknopol
Does innovation and industry
development in Oslo, mainly to
increase foreign investors.
Medicon Valley Academy
Building network in the
Copenhagen/Malmö-region between
industry, academia and public sector
to enhance growth within life science.
Scanbalt
International Cooperation
• Medicon Valley Academy (partner
agreement)
• Scanbalt (Steering group)
• EFB (European Federation of Biotechnology)
• Interreg IIIC Research Competence project
• BioBaltic IIIB Bio Medical Cluster
• Scanbalt Academy (6FP)
• Conferences (Scanbalt Forum, ECFG)
Strategies
How will MedCoast fulfill its business idea and generate a positive
growth environment? The strategies will direct our activities.
Initiate and facilitate connections for a
positive growth environment.
 Initiate collaborative biomedical projects.
 Business advisors to members.
 Supply the latest, relevant biomedical
information.
 Making MedCoast and its members known
following a well-defined marketing
communication plan.

Target groups
Academia
Researchers
Innovators
Technology Transfer Offices
Faculties
Industry
Large companies
Small companies
Start-ups
Science Parks
Service providers;
MedCoast
Incubators
Finance
IPR advisors
BioBan (Business Angel Network)
Institutional investors
Public Sector
Hospitals
Politicians
Regulators
Target groups’ prioritized need
Industry
Academia
Public Sector
Influence
Good citizen
Personnel recruitments
Network co-operations
Network co-operations
Financing
Company recruitments
Marketing
Network co-operations
Competence
Marketing
Network co-operations
Large companies
Small companies
Customer recruitments
Network co-operations
Specialized know-how
Marketing
Start-ups
Financial support
Network co-operations
Specialized know-how
Marketing
Science Parks
Customer recruitments
Industrial influence
Network co-operations
Service providers
Customer recruitments
Network co-operations
Marketing
Researchers
Innovators/TTO:s
Company recruitments
Financial support
Network co-operations
Specialized know-how
Faculties
Increased knowledge
Personnel recruitments
Network co-operations
Hospitals
Politicians
Industrial influence
Good citizen
Network co-operations
Regulators
Influence
Network co-operations
Good citizen
What can MedCoast do?
How do we satisfy the needs of the target groups – what is our offer?
Increased knowledge/Specialized know-how
 Newsletter and website publications on studies of trends (benchmarking).
 Seminars on important issues and workshop on finance, IP, legal etc.
 The database with company and clinical research information.
Financial support
 Facilitate financial, marketing and administrative services.
 Organizing joint-marketing activities.
 Agreements for member advantages.
Influence
 Cooperation with other bio-organizations.
 Making MedCoast and its members known among leading parties.
 Member meetings.
 Exhibitions.
Network co-operations
 Professional selected members.
 Member meetings.
Customer and personnel recruitments
 The database with company information.
 Marketing.
 Positive environment for researchers.
The mission of MedCoast
Initiate and facilitate collaborations, connections and
exchange of competence between the parties.
This will increase knowledge, improve understanding
and create a platform for fruitful relations.
Academia
Industry
Public Sector
On-going projects









Scandinavian Database
Microarrays
Bioinformatics
Proteomics
Biobank and genetic epidemiology
MarEGene
Protein structure and spectroscopy
Ethics
Bioimaging
Long-term goals
What shall MedCoast achieve within 10 years?
MedCoast long-term goals are to:
– become a strong trademark associated with professional
collaborations, frontline research, high innovations and
leading companies within biomedicine.
– establish the region as a biomedicine centre, well-respected
in Europe.
– become the preferred option for industry, academia and
hospitals when connecting biomedicine parties for successful
co-operations and when searching the latest information in
the field of biomedicine.
Short-term goals
What shall MedCoast achieve within the following years?
Strengthen the biomedical research.
Enhance entrepreneurship and commercialization
of innovations.
 Attract seed fund and venture capital.
 Strengthen the region’s position internationally.
 Influence governmental bodies to support the
vision of MedCoast.


ALL THIS NEED ACCESSABLE INFORMATION!
Database project vision






Improve Information availability
Stimulate cross border cooperation
Reduce cost by working together
Standardisation / Common network
standards add new features
Link the organisations (KI, MVA, Bio
Uppsala BioSweden and Scanbalt) closer
together
Add value for our members
Database should be based on:






Existing available infomation, if possible
Single registration of data
Include national information in the
Scandinavian region
Internet access and searchable
Regional monitoring and individual
updating of information
Access control for strategic information
Database project group:







Medicon Valley Academy
Scanbalt
BRG/Sahlgrenska Science Park
Uppsala Bio
Karolinska Institutet
Medcoast Scandinavia
Sweden Bio
Project Phases:




1. Company Database Demo Feb.2004
for MCS region
2. Launch of Company Database at
Bio2004 in San Fransisco (2 June 2004)
2. Common system layout for
Scandinavian Bio resource database
2004/2005
3. Updated data structure and project
admin. Dec. 2004
What do we want to achieve?
Add value for our members and collaboration partners
Generic model of the KI system
Web portal
Web-server
(database)
ODBC
ODBC
Local Database
Local web portal
Scandinavian
Common
Database
What is available today?
• Administration
• Maintenance system for updating information by
the users (Companies)
• Search applications
–
–
–
–
–
–
KI
SwedenBIO
Biosweden
MedCoast
Uppsala
Medicon Valley Academy
+ Scandinavian Common Corporate DB
The current database
•
•
General
– Company name
– Org. number
– Address, tel, fax
– E-post, Web-address
– Description of Company
– Established
– Co-names
– Key words
Key personnel
– Title
– Position
– E-mail
– Div
– (Boards, Scientific founders,
Advisory Board)
•
Classification
– 35 main categhories (MeSH)
– 26 Productt areas
– Activity
(Market/sale, Service, Production, R&D, div)
– Financial information
•
– Annual
• Turnover (+ % Medical, %
F&U, Asset turnover)
• No. Of emloyees
• Profit (+EBIT)
Others
– Administartion
– Acadermic partners
– FDA approvals
Classification System
• Tripple searchable
• Unlimited entities for
each company
• Dynamic
• Activity
–
–
–
–
R&D
Sale
Production
Services
• Medical Areas (MeSH)
– 35 # such as
•
•
•
•
Allergy & immunology
Medical Oncology
Neurology
Surgery
• Product
– 26 #,such as
•
•
•
•
•
Biomaterial
Biomedical knowlegde
Diagnostics
Pharma
IP advisors
MeSH-Index:




Medical Subject Heading (MeSH)
Launched by National Library of Medicine
(NLM, USA)
Structure standard for indexed databases
as MEDLINE
22,500 Descriptors (main headings)
133,000 Supplementary Concept Records
Hierarchical and ranking structure
Strategic info in demand:





IP-project database for
outlicensing/industrial
patrnership/investigations
Competence collaboration/mobility
Info channel for Governmental and public
use (Bibliometric and statistical data)
Funding sources (both public and private)
Interactive investment partnering
Scandinavian DB status:





Approx. 2000 companies included
Free search application
Basic information available
Links to participants DB for more details
Official Launch at Bio 2004
Best way to find us is at
www.medcoast.org